Micro-Leads Medical, based in Somerville, MA, showcased HD64, an emerging, high-resolution spinal cord stimulation therapy for treating chronic focal pains of the low-back, trunk, extremities and feet at NANS 2020. Anne Staylor, SmartTRAK's Managing Editor and Sr. Director of Advanced Technologies, attended the NANS 2020 Emerging Technologies Forum and saw this novel technology designed for the spinal cord stimulation market.
1 min read
NANS StartUp Spotlight: Micro-Leads Medical
By Lindsey Wolejko on 2/7/20 9:38 AM
4 min read
Issues in Medtech 2020: Recession, Taxes and Sterilization
By Lisa Mahan on 1/31/20 9:30 AM
The Orthopedic Market experienced healthy growth in H219 fueled by a strong Q319 in the face of difficult comps with the usual fourth-quarter bump due to the seasonality of elective procedures. Looking ahead, several key issues have the potential to impact the US market in 2020. From the economy to taxes, SmartTRAK takes a look at some of the bigger picture issues...
3 min read
SmartTRAK's Anne Staylor at NANS 2020 in Las Vegas
By Lindsey Wolejko on 1/27/20 9:00 AM
Anne Staylor, SmartTRAK's Managing Editor and Director of Advanced Technologies, is in Las Vegas attending NANS 2020, the North American Neurological Society's 23rd annual meeting, and, as you can see from the photo above taken at NANS, she is already thinking about NANS 2021 in Orlando. The theme of the this year's NANS is “Driving Innovation Through Science and Evidence.” Anne, who covers Neuromodulation for SmartTRAK, will be reporting on the meeting through articles and interviews...
6 min read
Know Before You Go: NANS 2020
By Thomas Wallick on 1/20/20 4:19 PM
Are you getting ready to head out to Las Vegas to attend NANS 2020 - the North American Neuromodulation Society 23rd Annual Meeting? We sat down with Anne Staylor, SmartTRAK's Managing Editor and Senior Director of Advanced Technologies for our new series, Know Before You Go, to find out what she's looking forward to ahead of NANS 2020.
NANS 2020, billed as the premier meeting in the field of neuromodulation, is being held this year at Caesars Palace in Las Vegas, NV, and will showcase the latest scientific research and technical advancements in neuromodulation.
To hear Anne's take on the upcoming meeting, just click on the following video to listen to the full interview. A transcript of the interview is also provided below the video.
7 min read
Preventing Incisional Hernias: Mesh vs Better Surgical Skills
By Doug Devens on 1/20/20 9:30 AM
A panel session at ACS Clinical Congress 2019 examines the evidence behind currently proposed techniques to prevent incisional hernias after midline laparotomy closure, including the use of prophylactic mesh and small-bite 4:1 suture closure.
At the American College of Surgeons (ACS) Clinical Congress 2019, there was an important session in which panelists discussed the advantages and disadvantages of using prophylactic mesh after closure of midline laparotomies to prevent incisional hernias. Ajita Prabhu, MD and Benjamin Poulose, MD moderated the panel session on October 28, 2019.
Heidi Miller, MD of University of New Mexico gave background on risk factors for incisional hernias, which she estimated at 12-13% incidence after closure of a laparotomy. She characterized incisional hernias as “mostly due to technical failures,” including poor wound hemostasis or coagulopathy, too much inflammation of the wound and the associated abnormal collagen structure, and sutures without proper tension. With respect to the latter topic, she described how she likes to view the hernia as a chronic wound, with proliferation and remodeling dependent on proper tension of approximation. She also described modifiable risk factors associated with the patient. Smoking and diabetes affect tissue perfusion, with strong data supporting tissue ischemia associated with smoking. Tissue perfusion greatly affects wound healing, as do modifiable factors that affect inflammation, including proper wound care, nutrition (especially vitamin A intake) and obesity, which is associated with chronic inflammation. Additionally, obesity is also associated with increased risk of wound dehiscence and increased mechanical stress tending to open the wound ...
4 min read
Q319 Soft Tissue Fixation Market Recap: Steady As She Goes
By Freddy Buntoum on 1/17/20 12:57 PM
Steady as she goes...Soft Tissue Fixation Market on track to achieve SmartTRAK estimates for FY 2019
For the third quarter of 2019, the WW Soft Tissue Fixation Market revenue was up +3.4% YoY. Aggregate growth for the quarter benefited from solid revenue growth in the Hip Labral Repair segment, which was up +10.1% YoY, based on SmartTRAK Financial Dashboard.
Focusing on the US region, the Soft Tissue Fixation market was up YoY. However, on a sequential basis, growth was slightly down, attributable to the seasonal nature of Sports Medicine where many surgeries are elective with Q4 generally seeing high procedure volumes. Aggregate growth for Q319 was pulled by notable growths in the Shoulder Soft Tissue Fixation and the Hip Labral Repair segments. Although Knee Soft Tissue Fixation represents the 2nd largest segment, revenue growth was marginal, with the moderate growth seen steady at slightly above ...
Among the many topics covered in the complete, comprehensive Q319 Soft Tissue Fixation Market Recap*, including all the news, financial data, revenues, charts and SmartTRAK's expert analysis, are:
20 min read
Abbott's Proclaim XR: Extended Battery Life in a Recharge-Free SCS
By Anne Staylor on 1/14/20 12:43 AM
Abbott’s Allen Burton, MD, discusses the Company’s new recharge-free Proclaim XR Neurostimulation System in an interview with SmartTRAK
In the market for Spinal Cord Stimulation (SCS), companies have been looking at different ways to extend the battery life of an implantable pulse generator (IPG) and minimize the amount of time patients spend recharging a device. One competitor that’s making advances in battery longevity is Abbott Laboratories.
Armed with its own research that showed patients do not like recharging, Abbott launched the recharge-free Proclaim Elite SCS in 2017 with a patient-centric strategy and an eye for capturing share in the US SCS market. Since then, there have been questions about battery life, and whether or not a recharge-free IPG would have to be replaced more frequently than a rechargeable SCS.
4 min read
Meet Stacy Spirito - Director of Sales
By Lindsey Wolejko on 1/10/20 12:55 PM
We are pleased to announce that Stacy Spirito has joined the team at SmartTRAK as Director of Sales. Stacy has spent 14+ years in the medical device and technology industries, most recently as an Account Executive with Gartner, working with Investors. Prior to that, Stacy was part of a sales team that launched a disruptive new medical device for breast cancer at Mammotome/Leica Biosystems.
Meet Stacy Spirito:
- Stacy, what is your role with SmartTRAK? My role at SmartTRAK is Director of Sales. I will be developing and managing the relationship with our clients and ensuring we are providing value and actionable insights to enable them to deliver on their key initiatives.
3 min read
Meet Anikó Szekér - Senior Analyst, Wound Care
By Lindsey Wolejko on 1/9/20 9:43 AM
SmartTRAK is pleased to welcome Anikó Szekér, the newest addition to our Wound Care team. Anikó has 10+ years of medical device experience in Wound Care and Surgical single use products. Before joining SmartTRAK, Anikó was Marketing Manager, Eastern Europe Wound Care and Surgical at Mölnlycke Health Care.
8 min read
SmartTRAK Seeking an Enterprise Sales Executive
By Sharon O'Reilly on 1/8/20 12:58 PM
Location: Northeast region of US (NY, NJ, MA, PA)
Full-time Position
Position:
BioMedGPS, a leading strategic advisory and healthcare analytics firm serving the life sciences industry, is seeking a Director of Enterprise Sales with extensive healthcare B2B experience for its SmartTRAK Business Intelligence platform and related products. Applicant must reside in the Northeastern region of the USA for easy access to major accounts.
SmartTRAK is the first business intelligence portal that provides real time data, analytics and curated content by a team of industry experts to help medical device executives make more informed strategic decisions. SmartTRAK is utilized by leading medical device companies within the orthopedic, wound care, regenerative medicine and neuro therapeutic areas. The Director of Sales will be responsible for selling SmartTRAK’s suite of business intelligence solutions to C- suite and other senior level executives, as well as building long term strategic programs and relationships at all levels of the enterprise.